| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2009/08/05 | 06:16 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/05 | 05:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/05 | 05:00 | Business Wire | Allos Therapeutics Reports Second Quarter 2009 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/07/23 | 23:06 | Business Wire | Allos Therapeutics Launches Peripheral T-Cell Lymphoma Website | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/07/22 | 21:00 | Business Wire | Allos Therapeutics to Report Second Quarter 2009 Results on August 4, 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/07/20 | 21:04 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/07/20 | 21:00 | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/07/20 | 20:55 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/07/07 | 22:03 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/07/07 | 21:07 | Marketwired | BridgewaterEquity.com Free Fundamental Sector & Market Research on OCR, GGC, NWD, MPW, ALTH and NEXM | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/07/07 | 21:00 | Business Wire | Allos Therapeutics Completes Enrollment in Randomized Phase 2b Trial of Pralatrexate in Patients with Advanced Non-Small Cell... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/29 | 21:40 | PR Newswire (US) | InvestorSoup.com Researches Market Movers: Applied Materials, Allscripts-Misys, Allos, ValueVision, BGC Partners and Warren Reso | NASDAQ:ALTH | |
| 2009/06/24 | 07:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/24 | 07:45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/24 | 07:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/24 | 07:43 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/24 | 07:41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/24 | 07:41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/24 | 07:40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/18 | 06:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/13 | 01:53 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/02 | 19:05 | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/06/01 | 22:00 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/05/30 | 21:00 | Business Wire | Allos Therapeutics Reports Updated Data from Pivotol Phase 2 PROPEL Study of Pralatrexate at 45th ASCO Annual Meeting | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/05/26 | 21:05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/05/26 | 21:00 | Business Wire | Allos Therapeutics Announces FDA Accepts Pralatrexate NDA for Filing and Grants the Application Priority Review Status | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/05/15 | 07:15 | Business Wire | Allos Therapeutics Announces Updated Data from Pivotol Phase 2 PROPEL Study of Pralatrexate to be Presented at ASCO 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/05/12 | 21:00 | Business Wire | Allos Therapeutics to Present at the Eighth Annual JMP Securities Research Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/05/06 | 06:01 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/05/06 | 05:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |